GlassScriptPhysician profile
Jason Khadavi
NPI 1831534197
$1,219.61
in general payments reported to CMS, 2019-2025
29 companies · $245 in 2025
The $245 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.14 · 2020: $57.05 · 2021: $209 · 2022: $246 · 2023: $169 · 2024: $227 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $640.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $156.09 | 2021-2024 | Nuzyra |
| Amgen INC. | $120.83 | 2024-2025 | Krystexxa |
| Integra Lifesciences Corporation | $107.80 | 2019-2022 | |
| Smith+Nephew, INC. | $102.51 | 2021-2024 | Grafix, Grafix Pl, Stravix Pl |
| Vertex Pharmaceuticals Incorporated | $66.19 | 2025 | |
| Organogenesis INC. | $64.60 | 2021-2022 | |
| Treace Medical Concepts, INC. | $64.04 | 2022-2024 | |
| Abbott Laboratories | $62.95 | 2021-2025 | Freestyle Libre 3 |
| Kowa Pharmaceuticals America, INC. | $40.04 | 2024-2025 | Zoryve |
| Polynovo North America LLC | $35.25 | 2024 | Novosorb Btm |
| Viiv Healthcare Company | $32.37 | 2025 | Apretude |
| Nvision Biomedical Technologies, INC. | $31.65 | 2022 | |
| Nevro Corp. | $31.49 | 2022 | |
| Mimedx Group, INC. | $28.43 | 2024 | |
| Medtronic, INC. | $24.69 | 2023 | Accurian |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $23.88 | 2021 | |
| Corium, LLC | $23.48 | 2023 | Azstarys |
| Depuy Synthes Sales INC. | $23.32 | 2021 | |
| Supernus Pharmaceuticals, INC. | $20.70 | 2023 | Qelbree |
| Tactile Systems Technology INC | $20.56 | 2022 | |
| Orthofix Medical, INC. | $17.98 | 2025 | Physio-Stim |
| Medartis INC. | $17.12 | 2023 | Aptus |
| Eisai INC. | $16.26 | 2020 | |
| Sunovion Pharmaceuticals INC. | $16.15 | 2020 | |
| Averitas Pharma INC. | $15.55 | 2023 | Qutenza |
| Apria Healthcare LLC | $15.33 | 2021 | |
| Paragon 28, INC. | $14.62 | 2021 | |
| Djo, LLC | $14.31 | 2024 | Aircast |
| Axogen | $11.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Khadavi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.